Target intelligence / Profile preview

Intestinal tight junction protein complex (TJ) (TJ)

Target
TJ
Molecular classification
Cell-cell junction, Protein complex, Structural protein
01

Overview

Intestinal tight junction protein complexes are specialized multi-protein structures located at the apical-most part of the lateral cell membranes in the intestinal epithelium (PubMed: 28123247). They serve as the primary determinant of the paracellular barrier, selectively regulating the passage of ions, water, and small molecules while excluding larger pathogens and toxins (NIH: PMC4216444). The complex consists of transmembrane proteins such as claudins, occludin, and junctional adhesion molecules (JAMs), which are anchored to the actin cytoskeleton by peripheral membrane proteins like zonula occludens-1 (ZO-1) (StatPearls: NBK513310). Dysfunction of these complexes, leading to increased intestinal permeability or leaky gut, is a hallmark of several gastrointestinal and systemic inflammatory conditions, including Celiac disease and IBD (PubMed: 31076401). Therapeutic interventions, such as zonulin antagonists like larazotide acetate, aim to restore junctional integrity and prevent the translocation of pro-inflammatory triggers (PubChem: CID 11511134).

Other names
Zonula occludensOccluding junctionIntestinal epithelial barrierTight junction complex
02

Mechanism of action

Modulation of paracellular permeability through the regulation of transmembrane proteins (claudins, occludin) and cytosolic scaffold proteins (zonula occludens), often via zonulin antagonism or activation of signaling pathways like MLCK or ClC-2 (PubMed: 31076401).

03

Biological functions

Barrier functionParacellular transport regulationCell polarity maintenanceSignal transduction
04

Disease associations

Celiac diseaseInflammatory bowel diseaseIrritable bowel syndromeType 1 diabetesNon-alcoholic fatty liver disease
05

Safety considerations

Potential for systemic absorption of luminal antigens (PubMed: 28123247)Off-target effects in other epithelial barriers (NIH: PMC4216444)Risk of infection if barrier is excessively compromised
06

Interacting drugs

Larazotide acetate

5 more in the full profile.

07

Biomarkers

Serum zonulinClaudin-3Lactulose/Mannitol ratioLipopolysaccharide (LPS)Intestinal fatty acid-binding protein (I-FABP)

Beyond the preview

Go deeper on Intestinal tight junction protein complex (TJ) (TJ).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Intestinal tight junction protein complex (TJ) (TJ).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call